Key result
Transcatheter occlusion of sinus venosus atrial septal defect using covered stents was feasible in 50% of patients, with no residual shunts or procedural complications observed in the treated cases.
Why the study?
Percutaneous treatment for atrial septal defects is typically restricted to the oval fossa, leaving other communications such as sinus venosus atrial septal defects traditionally referred for surgery.
Does transcatheter occlusion using covered stents in the superior vena cava successfully close sinus venosus atrial septal defects in adult patients?
Population
4 consecutive patients diagnosed with sinus venosus atrial septal defect by transesophageal…
Design
Case_series
Follow-up
3 months
Authors
Loading...
May expand percutaneous ASD options; hypothesis-generating and requires prospective validation before practice change.
Observational (n=4)
No
Does transcatheter occlusion using covered stents in the superior vena cava successfully close sinus venosus atrial septal defects in adult patients?
Transcatheter occlusion of sinus venosus atrial septal defect using covered stents is a feasible alternative to surgery in anatomically suitable patients.
Chamié et al. (2020) conducted an observational in Sinus venosus atrial septal defect (n=4). Transcatheter occlusion using covered stents was evaluated on Successful stent implantation. Transcatheter occlusion of sinus venosus atrial septal defect using covered stents was feasible in 50% of patients, with no residual shunts or procedural complications observed in the treated cases.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: